Prognostic factors for esophageal squamous cell Carcinoma-A Population-Based study in Golestan province, Iran, a high incidence area

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Aghcheli, Karim ^a   Marjani, Haji Amin ^a   Nasrollahzadeh, Dariush ^a,b   Islami, Farhad ^a,c   Shakeri, Ramin ^a   Sotoudeh, Masoud ^a   Abedi Ardekani, Behnoush ^a   Ghavamnasiri, Mohammad Reza ^d   Razaei, Ezzatollah ^d   Khalilipour, Elias ^a   Mohtashami, Samira ^d   Makhdoomi, Yasha ^d   Rajabzadeh, Rabea ^a   Merat, Shahin ^a   Sotoudehmanesh, Rasoul ^a   Semnani, Shahryar ^e   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNIC GROUP; FEMALE; HEALTH CARE ACCESS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROGNOSIS; SMOKING; SURVIVAL RATE; SURVIVAL TIME; URBAN AREA; CONFIDENCE INTERVAL; DEMOGRAPHY; ESOPHAGUS TUMOR; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; SURVIVAL;

NICOTIANA TABACUM;

AGED; CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; DEMOGRAPHY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 79960648188     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022152     Document Type: Article

References (46)

1. Kamangar F, Dores GM, Anderson WF, (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150.
2. Jemal A, Center MM, Desantis C, Ward EM, (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893-1907.
3. Blot WJ, McLaughlin JK, Fraumeni JF, (2006) Esophageal Cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention New York Oxford University Press pp. 697-706.
4. Trivers KF, Sabatino SA, Stewart SL, (2008) Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer 123: 1422-1428.
5. Steevens J, Botterweck AA, Dirx MJ, van den Brandt PA, Schouten LJ, (2010) Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 22: 669-678.
6. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, et al. (2004) Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 90: 1402-1406.
7. Klint A, Engholm G, Storm HH, Tryggvadottir L, Gislum M, et al. (2010) Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 49: 578-607.
8. Wang LS, Chow KC, Chi KH, Liu CC, Li WY, et al. (1999) Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 94: 1933-1940.
9. Peyre CG, Hagen JA, DeMeester SR, Van Lanschot JJ, Holscher A, et al. (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248: 979-985.
10. Lin CS, Chang SC, Wei YH, Chou TY, Wu YC, et al. (2009) Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 87: 1056-1065.
11. Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, et al. (2005) Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 3: 225-230.
12. Steyerberg EW, Neville B, Weeks JC, Earle CC, (2007) Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol 25: 2389-2396.
13. Sundelof M, Lagergren J, Ye W, (2008) Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 44: 1566-1571.
14. Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, et al. (2009) p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res 15: 3103-3109.
15. Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, et al. (2010) Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci 101: 1001-1006.
16. Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, et al. (2006) Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev 30: 14-19.
17. Cook-Mozaffari PJ, Azordegan F, Day NE, Ressicaud A, Sabai C, et al. (1979) Oesophageal cancer studies in the Caspian Littoral of Iran: results of a case-control study. Br J Cancer 39: 293-309.
18. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, et al. (2008) Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 98: 1857-1863.
19. Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, et al. (2004) Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev 13: 1068-1070.
20. Thompson WM, Halvorsen RA, Foster WL Jr, Williford ME, Postlethwait RW, et al. (1983) Computed tomography for staging esophageal and gastroesophageal cancer: reevaluation. AJR Am J Roentgenol 141: 951-958.
21. American Joint Committee on Cancer (2002) AJCC Cancer Staging Manual New York Springer-Verlag.
22. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
23. Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, et al. (2007) Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 10: 32-37.
24. Yeole BB, Kumar AV, (2004) Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India. Asian Pac J Cancer Prev 5: 175-182.
25. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, et al. (2008) Racial disparities in esophageal cancer treatment and outcomes. Ann Surg Oncol 15: 881-888.
26. Stockeld D, Backman L, Fagerberg J, Granstrom L, (2007) Esophageal cancer in Stockholm county 1978-1995. Acta Oncol 46: 1075-1084.
27. Faivre J, Forman D, Esteve J, Gatta G, (1998) Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 34: 2167-2175.
28. Baastrup R, Sorensen M, Hansen J, Hansen RD, Wurtzen H, et al. (2008) Social inequality and incidence of and survival from cancers of the oesophagus, stomach and pancreas in a population-based study in Denmark, 1994-2003. Eur J Cancer 44: 1962-1977.
29. Alidina A, Gaffar A, Hussain F, Islam M, Vaziri I, et al. (2004) Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Ann Oncol 15: 118-122.
30. Abdullah M, Karim AA, Goh KL, (2010) Late presentation of esophageal cancer: observations in a multiracial South-East Asian population. J Dig Dis 11: 28-33.
31. Jeffreys M, Stevanovic V, Tobias M, Lewis C, Ellison-Loschmann L, et al. (2005) Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health 95: 834-837.
32. Dubecz A, Sepesi B, Salvador R, Polomsky M, Watson TJ, et al. (2010) Surgical resection for locoregional esophageal cancer is underutilized in the United States. J Am Coll Surg 211: 754-761.
33. Boffetta P, Hecht S, Gray N, Gupta P, Straif K, (2008) Smokeless tobacco and cancer. Lancet Oncol 9: 667-675.
34. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, et al. (2009) A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10: 1033-1034.
35. Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, et al. (2010) Cohort Profile: The Golestan Cohort Study-a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol pp. 52-59.
36. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, et al. (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62: 4491-4498.
37. Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J, (2006) Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res 72: 3-11.
38. Kranzfelder M, Buchler P, Lange K, Friess H, (2010) Treatment options for squamous cell cancer of the esophagus: a systematic review of the literature. J Am Coll Surg 210: 351-359.
39. Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, et al. (2005) Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 6: 864-870.
40. Malthaner R, Wong RK, Spithoff K, (2010) Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol) 22: 250-256.
41. Hajian-Tilaki KO, (2001) Factors affecting the survival of patients with oesophageal carcinoma under radiotherapy in the north of Iran. Br J Cancer 85: 1671-1674.
42. Salek R, Bezenjani SE, Saedi HS, Ashkiki MH, Hosainzade SM, et al. (2009) A geographic area with better outcome of esophageal carcinoma: is there an effect of ethnicity and etiologic factors? Oncology 77: 172-177.
43. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, et al. (2010) Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer.
44. Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, et al. (1999) Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 80: 1281-1288.
45. Wallace MB, Nietert PJ, Earle C, Krasna MJ, Hawes RH, et al. (2002) An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 74: 1026-1032.
46. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD, (2008) Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98: 547-557.